The results of the PROVE-IT trial, which is expected to be concluded in March next year, is being eagerly awaited by health professionals as it will define the role of various statins and the possible role of antibiotics in treating heart disease. TANG WENG HENG has the story.
THE lower a drug reduces a patient’s bad cholesterol (low density lipoproteins, or LDLs), the better. This long-held belief is being further investigated by medical researchers as a result of a clinical trial, with results being expected in March 2004.
